Inflammation and Mortality in COVID-19 Hospitalized Patients With and Without Type 2 Diabetes
제2형 당뇨병이 있거나 없는 COVID-19 입원 환자의 염증 및 사망률
Article
Published on
Journal: The Journal of Clinical Endocrinology and Metaboli [Category] Coronavirus, COVID19(2023년), SARS, 바이오마커,
Journal: The Journal of Clinical Endocrinology and Metaboli [Category] Coronavirus, COVID19(2023년), SARS, 바이오마커,
[키워드] 95% CI
adjusted odds ratio
association
benefit
Case-control
center
chemokine
chemokines
Columbia University
Columbia University Irving Medical Center
components
conducted
COVID-19
COVID-19 mortality
COVID-19 patient
CXCL10
CXCL8
cytokine
Cytokine storm
Cytokines
death
determine
diabete
diabetes
elevated
hospitalized patient
hospitalized patients
Hypothesis
IFN-γ
IL-1β
IL-6
IL-6 inhibitor
IL-8
immunoassays
Inflammation
inflammatory chemokine
inflammatory chemokines
Inflammatory cytokine
Inflammatory marker
inflammatory markers
innate immune pathway
Innate immunity
interferon
interleukin
Intervention
IP10
log-transformed
logistic regression models
marker
Mortality
Necrosis
patients with diabetes
positive
Principal component
principal components
Protein
quantified
Regression model
SARS-CoV-2
serum
Serum level
Significant
significantly
similarities
similarity
stratified
TNF-α
Tumor
tumor necrosis
tumor necrosis factor
tumor necrosis factor α
Type
type 2 diabete
type 2 diabetes
were used
with COVID-19
[DOI] 10.1210/clinem/dgac003 PMC 바로가기 [Article Type] Article
[DOI] 10.1210/clinem/dgac003 PMC 바로가기 [Article Type] Article